These studies support the notion that there are some clinical settings in humans in which Hx is substantially depleted, paving the way for further studies in humans to investigate the potential therapeutic use of Hx to treat heme-amplified inflammation in infectious diseases. This evidence concerns the gene HPX and infectious disease.